William Blair analyst Andy Hsieh initiated coverage of BioAge Labs (BIOA) with a Market Perform rating.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOA:
- Hold Rating for BioAge Labs, Inc.: Balancing Innovative Potential with Competitive and Developmental Challenges
- BIOA Lawsuit Alert! Class Action Lawsuit Against BioAge Labs, Inc.
- Nine new option listings on February 12th
- BioAge Labs provides updates, terminates development of azelaprag
- Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline